Dentons Advises STADA Group on Acquisition of US$660 Million Pharmaceutical Portfolio From Takeda in 11 Countries, Including Russia and CIS
November 14, 2019
November 14, 2019
MOSCOW, Russia, Nov. 14 -- Dentons, a law firm, issued the following news release:
Dentons has advised STADA group on the execution of an asset purchase agreement for more than 20 Rx and OTC drugs and dietary supplements from Takeda group in 11 countries.
Dentons' team assisted STADA at each phase of the deal - from due diligence of the target assets up to signing - supporting the purchaser on a wide range of issues relating to laws of Russia, Georgia and CIS countries. . . .
Dentons has advised STADA group on the execution of an asset purchase agreement for more than 20 Rx and OTC drugs and dietary supplements from Takeda group in 11 countries.
Dentons' team assisted STADA at each phase of the deal - from due diligence of the target assets up to signing - supporting the purchaser on a wide range of issues relating to laws of Russia, Georgia and CIS countries. . . .